A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

• Status: Completed
• Trial end date: 2003-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of osteoarthritis of the knee.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Celecoxib; Rofecoxib

Criteria

Inclusion Criteria:

• Osteoarthritis of the knee which requires treatment with medication for pain relief

Exclusion Criteria:

• Any known allergy to the study drug